Sponsored by
This project was funded by the Musella Foundation. It shows a new way of enhancing the effect of Temodar on Glioblastomas (in the lab at this point), in cells that overexpress either wild type or mutated P53 gene.
p28-Mediated Activation of p53 in G2–M Phase of the Cell Cycle Enhances the Efficacy of DNA Damaging and Antimitotic Chemotherapy